Export Full Drugs Database Catalog
EGYPTIAN PHARMACEUTICAL DIRECTORY
FARCOSOLVIN 24 CAPS.
OFFICIAL RETAIL PRICE
EGP 15.25
Active Molecule
AMBROXOL + GUAIFENESIN + THEOPHYLLINE
Form & Route
Oral Solid (Tablets / Capsules)
Manufacturer
PHARCO
Therapeutic Class
MUCOLYTIC
Cost-Saving Equivalent Available: You can save up to EGP 10.05 by switching to TRISOLVIN 10 SOFT GELATIN CAPS. (EGP 5.20).
Commercial brands in Egypt sharing the exact same active molecule & dosage form.
Oral Liquid (Syrup / Suspension)
•
PHARCO
EGP 43.00
+EGP 27.75
Oral Solid (Tablets / Capsules)
•
SIGMA > FUTURE PHARMACEUTICAL INDUSTRIES (FPI)
EGP 6.00
Saves EGP 9.25
Oral Liquid (Syrup / Suspension)
•
GLOBAL NAPI PHARMACEUTICALS > FUTURE PHARMACEUTICAL INDUSTRIES (FPI)
EGP 6.25
Saves EGP 9.00
Oral Solid (Tablets / Capsules)
•
GLAXO SMITHKLINE
EGP 5.20
Saves EGP 10.05
Commercial brands in MUCOLYTIC that achieve equivalent therapeutic outcomes.
EGP 28.00
+EGP 12.75
EGP 19.20
+EGP 3.95
ACETYLCYSTEINE
Eff
•
JEDCO INT. CO. FOR PHARMACEUTICALS > ARAX PHARM. IND.
EGP 45.00
+EGP 29.75
ACETYLCYSTEINE
Eff
•
JEDCO INT. CO. FOR PHARMACEUTICALS > ARAX PHARM. IND.
EGP 44.00
+EGP 28.75
EGP 8.00
Saves EGP 7.25
EGP 94.50
+EGP 79.25
EGP 71.00
+EGP 55.75
EGP 55.00
+EGP 39.75
EGP 70.00
+EGP 54.75
EGP 70.00
+EGP 54.75
EGP 64.00
+EGP 48.75
EGP 7.50
Saves EGP 7.75
EGP 5.50
Saves EGP 9.75
EGP 16.00
+EGP 0.75
EGP 9.25
Saves EGP 6.00
CARBOCYSTEINE
Oral Liquid (Syrup / Suspension)
•
SANOFI
EGP 5.80
Saves EGP 9.45
EGP 6.80
Saves EGP 8.45
EGP 7.00
Saves EGP 8.25
EGP 7.00
Saves EGP 8.25
EGP 8.00
Saves EGP 7.25
EGP 50.00
+EGP 34.75
EGP 35.00
+EGP 19.75
EGP 25.00
+EGP 9.75
EGP 10.50
Saves EGP 4.75
EGP 9.00
Saves EGP 6.25
EGP 35.00
+EGP 19.75
EGP 29.00
+EGP 13.75
EGP 23.00
+EGP 7.75
EGP 6.00
Saves EGP 9.25
N.ACETYL CYSTEINE
Oral Solid (Tablets / Capsules)
•
BRAND NUTRITION > MEGA PHARMA
EGP 150.00
+EGP 134.75
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.